Japan’s AnGes Acquires EmendoBio, Eying High Precision Gene-Editing Technology
AnGes, Inc. is a biopharmaceutical company headquartered in Japan that specializes in gene-based medicines. On December 15th, it announced the acquisition of Emendo Biotherapeutics, a CRISPR gene-editing company, for a …
Read More